Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

C3 Jian, a US Dental Company with China Connections, Raises $30 Million

publication date: Feb 29, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
C3 Jian, a spinoff from UCLA, announced a new $30 million funding round, which will allow the company to develop its lead peptide drug for dental caries (tooth decay or cavities) and begin US clinical trials. In 2010, C3 Jian established a China subsidiary, Chengdu Sen Nuo Wei Biotechnology, which opened a clinical research center with West China School of Stomatology at Sichuan University. The center will conduct clinical trials of new oral healthcare products in China. More details....

Share this with colleagues:  

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...